DERM (STOCKS)
Journey Medical Corporation Common Stock
$7.710000
-0.280000 (-3.50%)
Prev close: $7.990000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Claude Maraoui
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $256.24M
- Employees
- 41
- P/E (TTM)
- -21.00
- P/B (TTM)
- 8.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $82.87M |
| Benefits Costs and Expenses | $221.05M |
| Cost Of Revenue | $5.13M |
| Costs And Expenses | $286.63M |
| Gross Profit | $77.74M |
| Nonoperating Income/Loss | $7.39M |
| Operating Expenses | $282.43M |
| Selling, General, and Administrative Expenses | $210.15M |
| Research and Development | $71.39M |
| Operating Income/Loss | -$203.75M |
| Income/Loss From Continuing Operations After Tax | -$212.23M |
| Income/Loss From Continuing Operations Before Tax | -$138.17M |
| Interest Expense, Operating | $14.92M |
| Net Income/Loss | -$212.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$212.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$212.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $436.24M |
| Current Assets | $412.52M |
| Inventory | $23.51M |
| Other Current Assets | $389.01M |
| Noncurrent Assets | $23.72M |
| Fixed Assets | $828.00K |
| Other Non-current Assets | $22.89M |
| Liabilities | $421.76M |
| Current Liabilities | $58.64M |
| Accounts Payable | $11.25M |
| Wages | $8.77M |
| Other Current Liabilities | $38.62M |
| Noncurrent Liabilities | $363.12M |
| Long-term Debt | $109.15M |
| Other Non-current Liabilities | $253.97M |
| Equity | $14.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.48M |
| Liabilities And Equity | $436.24M |
| Net Cash Flow From Operating Activities | -$215.17M |
| Net Cash Flow From Operating Activities, Continuing | -$215.17M |
| Net Cash Flow From Investing Activities | -$68.78M |
| Net Cash Flow From Investing Activities, Continuing | -$68.78M |
| Net Cash Flow From Financing Activities | $213.74M |
| Net Cash Flow From Financing Activities, Continuing | $213.74M |
| Net Cash Flow | -$70.22M |
| Net Cash Flow, Continuing | -$70.22M |
| Comprehensive Income/Loss | -$211.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$211.96M |
| Other Comprehensive Income/Loss | $266.00K |